REMS
FDA Eliminates REMS for 6 CAR T-Cell Immunotherapies
The FDA announced it has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for six currently approved ...
JULY 8, 2025
Update: No Need for ESA Risk Evaluation and Mitigation Strategy
The ESA Risk Evaluation and Mitigation Strategy is no longer necessary to ensure that the benefits of ...
APRIL 18, 2017
Load more